Position history for BNP Paribas Asset Management Holding S.A.'s holdings in CYTOKINETICS INC
BNP Paribas Asset Management Holding S.A. holds 714,344 shares of CYTK (CYTOKINETICS INC), worth $47.1M as of 2026-Q1. The position was decreased (-13.7% shares). CYTK represents 0.1% of BNP Paribas Asset Management Holding S.A.'s portfolio.
Current Value
$47.1M
Current Shares
714,344
Total Value Change
+$26.3M
Total Shares Change
+330,302
Other major holders of CYTK: BlackRock Finance, Inc., BlackRock, Inc.
Decreased |
| 714,344 |
-13.7% |
| $47.1M |
| 0.1% |
| $60.72 |
0 |
| 2025-Q4 | Increased | 827,863 | +5.5% | $52.6M | 0.1% | $61.37 | 31 |
| 2025-Q3 | Increased | 785,000 | +16.1% | $43.1M | 0.1% | $53.89 | 40 |
| 2025-Q2 | Increased | 676,280 | +29.4% | $22.3M | 0.1% | $33.16 | 36 |
| 2025-Q1 | Increased | 522,468 | +6.8% | $21M | 0.1% | $43.19 | 30 |
| 2024-Q4 | Increased | 489,362 | +49.2% | $23M | 0.1% | $47.15 | 39 |
| 2024-Q3 | Decreased | 328,072 | -14.6% | $17.3M | 0.0% | $52.34 | 0 |
| 2024-Q2 | Increased | 384,042 | +8.3% | $20.8M | 0.1% | $54.18 | 31 |